China’s Rise in Drug Development Looms Over U.S.
At the annual American Society of Clinical Oncology (ASCO) meeting in Chicago this June, industry leaders and researchers observed a significant shift in the global pharmaceutical landscape as China’s biotechnology sector unveiled a growing portfolio of high-impact clinical trial data. This surge in innovation, characterized by a rapid increase in novel oncology drug development, has…